Sufferers of type 2 diabetes may one day be able to control their condition and reduce the number of...
Sufferers of type 2 diabetes may one day be able to control their condition and reduce the number of injections they have to take each week from 14 to one, if Canadian research comes to fruition.
Researchers at the University of Toronto discovered a re-formulated version of the drug Exenatide was better at controlling blood sugar levels than the current one, which needs to be injected twice a day.
The preliminary study reported its findings as: "Exenatide once weekly resulted in significantly greater improvements of glycaemic control than Exenatide given twice a day, with no increased risk of hypoglycaemia and similar reduction in bodyweight."
Diabetes UK said more research was needed to bolster the findings, although the charity acknowledged that the results were "promising".
It did acknowledge that more research and confirmation of the results could lead to a change in practice.
